Literature DB >> 18800073

The IL-10R1 S138G loss-of-function allele and ulcerative colitis.

P Grundtner1, S Gruber, S S Murray, S Vermeire, P Rutgeerts, T Decker, P L Lakatos, C Gasche.   

Abstract

Genetic predisposition is a risk factor for the development of inflammatory bowel diseases (IBDs). Disruption of the interleukin (IL)-10 pathway in mice causes intestinal inflammation similar to human IBD. Two common non-synonymous IL-10R1 variants, S138G and G330R, were cloned and expressed in HeLa and Ba/F3. A reduction in IL-10-induced STAT1 and STAT3 activation was seen for IL-10R1-S138G (but not IL-10R1-G330R) by phosphospecific western blotting in both cell types. When analyzing 52 world populations for the presence of IL-10R1 variants, a strong dissimilarity was found between major geographical regions. In addition, when 182 IBD-parent trios were genotyped for both variants, a reduced transmission of haplotype -7 (carrying the S138G variant allele) to offspring with ulcerative colitis (UC) was observed. This UC-protective effect of S138G was confirmed in a Hungarian cohort (n=185, allele frequency 11.6 versus 17.5%; P=0.017) but not in an independent Belgian cohort (n=666, allele frequency 15.9 versus 15.5%; P=0.8). In conclusion, the IL-10R1 S138G variant is a loss-of-function allele for IL-10-induced STAT1 and STAT3 activation but does not protect from UC susceptibility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18800073     DOI: 10.1038/gene.2008.72

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  9 in total

1.  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.

Authors:  Efe Sezgin; Sher L Hendrickson; Douglas A Jabs; Mark L Van Natta; Richard A Lewis; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

2.  Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease.

Authors:  Hongchao Lv; Yongshuai Jiang; Jin Li; Mingming Zhang; Zhenwei Shang; Jiajia Zheng; Xin Wu; Panpan Liu; Ruijie Zhang; Huimin Yu
Journal:  Mol Biol Rep       Date:  2014-01-10       Impact factor: 2.316

3.  An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.

Authors:  M Finsterbusch; V Khare; C Campregher; R Evstatiev; C Gasche
Journal:  Genes Immun       Date:  2011-06-09       Impact factor: 2.676

Review 4.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

5.  Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS.

Authors:  Efe Sezgin; Douglas A Jabs; Sher L Hendrickson; Mark Van Natta; Alexander Zdanov; Richard Alan Lewis; Michael W Smith; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

Review 6.  The molecular basis of IL-10 function: from receptor structure to the onset of signaling.

Authors:  Mark R Walter
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

7.  IFNβ autocrine feedback is required to sustain TLR induced production of MCP-1 in macrophages.

Authors:  Michael J Pattison; Kirsty F MacKenzie; Suzanne E Elcombe; J Simon C Arthur
Journal:  FEBS Lett       Date:  2013-03-28       Impact factor: 4.124

8.  Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1.

Authors:  Sabine G Gruber; Maria Gloria Luciani; Paul Grundtner; Alexander Zdanov; Christoph Gasche
Journal:  Eur J Immunol       Date:  2008-12       Impact factor: 6.688

9.  Novel missense mutation in the NOD2 gene in a patient with early onset ulcerative colitis: causal or chance association?

Authors:  Martina Girardelli; Josef Vuch; Alberto Tommasini; Sergio Crovella; Anna Monica Bianco
Journal:  Int J Mol Sci       Date:  2014-03-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.